Saturday, November 22, 2008

Rheumatoid Arthritis Home>
Rheumatoid Arthritis News>
Vaccine may double brain tumor survival

Vaccine may double brain tumor survival

(Medical News Today) UPDATED 2008-06-03

Researchers from Duke University say that a new vaccine may double the survival rate for patients with a common and deadly brain tumor. The vaccine targets a protein found in some tumors and helps the immune system kill it, researchers say. In a Phase II clinical trail of 23 patients, the vaccine doubled the survival rate of patients and more than doubled the length of time before the cancer's recurrence. Read full story >

See all Rheumatoid Arthritis News

Bookmark

Was this helpful? Yes

Save to My Home
Want to keep this page handy for later? Click Save to My Home and we'll add it to your My Home area.

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyRACentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2008. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.